<--- Back to Details
First PageDocument Content
Coagulation system / Von Willebrand disease / Platelet / Coagulation / Von Willebrand factor / Bleeding / Thrombocytopenia / Idiopathic thrombocytopenic purpura / Desmopressin / Blood / Anatomy / Biology
Date: 2014-06-23 16:09:27
Coagulation system
Von Willebrand disease
Platelet
Coagulation
Von Willebrand factor
Bleeding
Thrombocytopenia
Idiopathic thrombocytopenic purpura
Desmopressin
Blood
Anatomy
Biology

Bleeding Disorders: Characterization,Dental Considerations and Management

Add to Reading List

Source URL: umanitoba.ca

Download Document from Source Website

File Size: 649,59 KB

Share Document on Facebook

Similar Documents

Blood / Medicine / Anatomy / Transfusion medicine / Hematology / Blood products / Coagulation system / Platelet / Blood transfusion / Hematocrit / Bleeding / Blood type

Center Information: Subcenter: Inland Northwest Blood Center Inland Northwest Blood Center 210 W. Cataldo Ave.

DocID: 1riKA - View Document

Cell biology / Biology / Blood / Programmed cell death / Apoptosis / Coagulation system / Cell signaling / Induced stem cells / Caspase / Platelet / Thrombopoiesis / Angiogenesis

Microsoft Wordfile00

DocID: 1r9dZ - View Document

Blood / Coagulation system / Anatomy / CSL Behring / Von Willebrand disease / Factor VIII / Coagulation / CSL Limited / Hereditary angioedema / Haemophilia / Factor IX / Factor VII

News Releases Global Home | CSL Behring US | CSL Plasma | All CSL Behring Web Sites  

DocID: 1qHpD - View Document

Medicine / Coagulation system / Thrombin / Antibody / Syringe / Surgical suture / Draft:Professor Dr. S Tsakas II

RECOTHROM, Thrombin topical (Recombinant) Package Insert

DocID: 1qv5K - View Document

Finance / Money / Economy / Transfusion medicine / Blood products / Corporate finance / Venture capital / Coagulation system / Platelet / Nesta / Bleeding / Seed money

Quester leads £3.1million investment in Haemostatix 23 January 2006 – Quester, a leading UK venture capital company, announced today that it has led a £3.1million investment in Haemostatix Ltd, a drug design and deve

DocID: 1qk7W - View Document